A Secreted Serine-Threonine Kinase Determines Virulence in the Eukaryotic Pathogen Toxoplasma gondii

Toxoplasma gondii strains differ dramatically in virulence despite being genetically very similar. Genetic mapping revealed two closely adjacent quantitative trait loci on parasite chromosome VIIa that control the extreme virulence of the type I lineage. Positional cloning identified the candidate virulence gene ROP18, a highly polymorphic serine-threonine kinase that was secreted into the host cell during parasite invasion. Transfection of the virulent ROP18 allele into a nonpathogenic type III strain increased growth and enhanced mortality by 4 to 5 logs. These attributes of ROP18 required kinase activity, which revealed that secretion of effectors is a major component of parasite virulence.

[1]  G. Labesse,et al.  The ROP2 family of Toxoplasma gondii rhoptry proteins: Proteomic and genomic characterization and molecular modeling , 2006, Proteomics.

[2]  L. Sibley,et al.  Genetic Divergence of Toxoplasma gondii Strains Associated with Ocular Toxoplasmosis, Brazil , 2006, Emerging infectious diseases.

[3]  Oliver Billker,et al.  Protein kinases as targets for antimalarial intervention: Kinomics, structure-based design, transmission-blockade, and targeting host cell enzymes. , 2005, Biochimica et biophysica acta.

[4]  L. Sibley,et al.  Genotyping of Toxoplasma gondii Strains from Immunocompromised Patients Reveals High Prevalence of Type I Strains , 2005, Journal of Clinical Microbiology.

[5]  Peter J Bradley,et al.  Proteomic Analysis of Rhoptry Organelles Reveals Many Novel Constituents for Host-Parasite Interactions in Toxoplasma gondii* , 2005, Journal of Biological Chemistry.

[6]  C. Glover,et al.  Gene expression profiling for hematopoietic cell culture , 2006 .

[7]  Ian T. Paulsen,et al.  Composite genome map and recombination parameters derived from three archetypal lineages of Toxoplasma gondii , 2005, Nucleic acids research.

[8]  宁北芳,et al.  疟原虫var基因转换速率变化导致抗原变异[英]／Paul H, Robert P, Christodoulou Z, et al//Proc Natl Acad Sci U S A , 2005 .

[9]  U. Groß,et al.  Apoptosis and its modulation during infection with Toxoplasma gondii: molecular mechanisms and role in pathogenesis. , 2005, Current topics in microbiology and immunology.

[10]  B. Butcher,et al.  Manipulation of mitogen‐activated protein kinase/nuclear factor‐κB‐signaling cascades during intracellular Toxoplasma gondii infection , 2004, Immunological reviews.

[11]  L. Sibley.  Intracellular Parasite Invasion Strategies , 2004, Science.

[12]  J. Ajioka,et al.  Recent Expansion of Toxoplasma Through Enhanced Oral Transmission , 2003, Science.

[13]  Li Li,et al.  ToxoDB: accessing the Toxoplasma gondii genome , 2003, Nucleic Acids Res..

[14]  J. Boothroyd,et al.  Population biology of Toxoplasma gondii and its relevance to human infection: do different strains cause different disease? , 2002, Current opinion in microbiology.

[15]  J. Dubey,et al.  Identification of quantitative trait loci controlling acute virulence in Toxoplasma gondii , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[16]  L. Sibley,et al.  Transepithelial Migration of Toxoplasma gondii Is Linked to Parasite Motility and Virulence , 2002, The Journal of experimental medicine.

[17]  L. Sibley,et al.  Acute Toxoplasmosis Leads to Lethal Overproduction of Th1 Cytokines1 , 2001, The Journal of Immunology.

[18]  A. Hehl,et al.  Success and Virulence in Toxoplasma as the Result of Sexual Recombination Between Two Distinct Ancestries , 2001, Science.

[19]  J. Boothroyd,et al.  Unusual abundance of atypical strains associated with human ocular toxoplasmosis. , 2001, The Journal of infectious diseases.

[20]  E. Denkers,et al.  IFN-γ Overproduction and High Level Apoptosis Are Associated with High but Not Low Virulence Toxoplasma gondii Infection1 , 2001, The Journal of Immunology.

[21]  D. Roos,et al.  Defining the cell cycle for the tachyzoite stage of Toxoplasma gondii. , 2001, Molecular and biochemical parasitology.

[22]  I. D. Manger,et al.  Microarray Analysis Reveals Previously Unknown Changes in Toxoplasma gondii-infected Human Cells* , 2001, The Journal of Biological Chemistry.

[23]  L. Sibley,et al.  Toxoplasma evacuoles: a two‐step process of secretion and fusion forms the parasitophorous vacuole , 2001, The EMBO journal.

[24]  J. M. Rubio,et al.  Genotypic Characterization of Toxoplasma gondii Strains Associated with Human Toxoplasmosis in Spain: Direct Analysis from Clinical Samples , 2001, Journal of Clinical Microbiology.

[25]  T. Wreghitt,et al.  Toxoplasmosis: A comprehensive clinical guide , 2001 .

[26]  L. Sibley,et al.  Acute virulence in mice is associated with markers on chromosome VIII in Toxoplasma gondii , 1996, Infection and immunity.

[27]  L. Sibley,et al.  Toxoplasma gondii comprises three clonal lineages: correlation of parasite genotype with human disease. , 1995, The Journal of infectious diseases.

[28]  K. Joiner,et al.  The Toxoplasma gondii rhoptry protein ROP 2 is inserted into the parasitophorous vacuole membrane, surrounding the intracellular parasite, and is exposed to the host cell cytoplasm , 1994, The Journal of cell biology.

[29]  L. David Sibley,et al.  Virulent strains of Toxoplasma gondii comprise a single clonal lineage , 1992, Nature.

[30]  B. Bainbridge,et al.  Genetics , 1981, Experientia.